Market Cap 154.44B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.30
Forward PE 9.02
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 40,560,100
Avg Vol 46,212,879
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 75%
Beta 0.47
Analysts Sell
Price Target $28.82

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Mountainmannn
Mountainmannn Mar. 12 at 1:11 PM
$ABUS no reason to not park some 401k money here and collect free money at settlements! $PFE
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Mar. 12 at 12:58 PM
$KMB $HOOD $KVUE $PFE These are the kinds of tickers than will do okay in the upcoming inflation surge.
0 · Reply
enochmacmillan
enochmacmillan Mar. 12 at 9:48 AM
$PFE $DHR The bulls have single-handedly reversed the market structure.
0 · Reply
judgeyoung2
judgeyoung2 Mar. 11 at 11:44 PM
$GPCR remember there were 7 parties circling Metsera at one point. $NVO came back in to force the bid higher on $PFE. we know there’s a lot of interest in this space. it’s just a question of who is next to be acquired. i think it’s interesting that Structure isn’t at this Leerink conference despite attending the last two years. we are still waiting on 44 week data. let’s say it shows no plateau… i don’t see why this couldn’t push back to $100. and big players will see the data first. that’s what happened with Metsera. so, this is all speculation of course, but i think Structure is next to be scooped up, contingent on the 44 week data being good. or maybe i am just a crackhead.
1 · Reply
Davidendz
Davidendz Mar. 11 at 8:45 PM
2026 immuno and vax sector is heating up. $MRNA showing durable melanoma control. $BNTX lining up a catalyst heavy year. $PFE staying active on deals. Then $BIOV $BVAXF expanding DPX optionality with the Adiverna mRNA vet collab right after positive Phase 2 bladder data.
0 · Reply
RocroBio
RocroBio Mar. 11 at 7:18 PM
0 · Reply
RocroBio
RocroBio Mar. 11 at 7:18 PM
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 11 at 6:51 PM
$PFE needs a Green or Red? drinking game today.
1 · Reply
DragonAlgo
DragonAlgo Mar. 11 at 6:28 PM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-03-13 | Strike: $26.50 | Type: CALL Option Plan (premium): Entry: $0.75 Stop: $0.54 TP1: $0.98 TP2: $1.27 TP3: $1.80 Rules-based execution profile. 🔗 https://dragonalgo.com
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Mar. 11 at 6:05 PM
$PFE Whats better than going green five times in one day?
3 · Reply
Latest News on PFE
China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 6 days ago

China approves Pfizer GLP-1 drug for weight management


Seven S&P500 Ideal 'Safer' March Dividend Dogs

Mar 4, 2026, 11:31 AM EST - 7 days ago

Seven S&P500 Ideal 'Safer' March Dividend Dogs

AMCR ARE BBY BEN BXP CAG CCI


Pfizer's Quiet Cash Comeback

Mar 3, 2026, 9:50 AM EST - 8 days ago

Pfizer's Quiet Cash Comeback


Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 9 days ago

Pfizer CEO flags issues with FDA's vaccine leadership


Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 16 days ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug


Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 16 days ago

Pfizer in diabetes drug deal with Sciwind Biosciences


Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Feb 20, 2026, 11:47 PM EST - 19 days ago

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors


Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 21 days ago

Is There 25% Downside For Pfizer Stock?


Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 22 days ago

Pfizer: The Rebound Looks Unsustainable


Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 6:08 PM EST - 4 weeks ago

Pfizer: A Great Opportunity Post Earnings


2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 4 weeks ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD


Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 4 weeks ago

Is Pfizer Stock Now A Value Trap?


Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 3:00 PM EST - 5 weeks ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript


Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 2:02 PM EST - 5 weeks ago

Pfizer: Messy Q4 Earnings Mask An Improving Business


Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 5 weeks ago

Silver Surges Over 15%; Pfizer Earnings Top Views


Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:21 AM EST - 5 weeks ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand


Mountainmannn
Mountainmannn Mar. 12 at 1:11 PM
$ABUS no reason to not park some 401k money here and collect free money at settlements! $PFE
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Mar. 12 at 12:58 PM
$KMB $HOOD $KVUE $PFE These are the kinds of tickers than will do okay in the upcoming inflation surge.
0 · Reply
enochmacmillan
enochmacmillan Mar. 12 at 9:48 AM
$PFE $DHR The bulls have single-handedly reversed the market structure.
0 · Reply
judgeyoung2
judgeyoung2 Mar. 11 at 11:44 PM
$GPCR remember there were 7 parties circling Metsera at one point. $NVO came back in to force the bid higher on $PFE. we know there’s a lot of interest in this space. it’s just a question of who is next to be acquired. i think it’s interesting that Structure isn’t at this Leerink conference despite attending the last two years. we are still waiting on 44 week data. let’s say it shows no plateau… i don’t see why this couldn’t push back to $100. and big players will see the data first. that’s what happened with Metsera. so, this is all speculation of course, but i think Structure is next to be scooped up, contingent on the 44 week data being good. or maybe i am just a crackhead.
1 · Reply
Davidendz
Davidendz Mar. 11 at 8:45 PM
2026 immuno and vax sector is heating up. $MRNA showing durable melanoma control. $BNTX lining up a catalyst heavy year. $PFE staying active on deals. Then $BIOV $BVAXF expanding DPX optionality with the Adiverna mRNA vet collab right after positive Phase 2 bladder data.
0 · Reply
RocroBio
RocroBio Mar. 11 at 7:18 PM
0 · Reply
RocroBio
RocroBio Mar. 11 at 7:18 PM
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 11 at 6:51 PM
$PFE needs a Green or Red? drinking game today.
1 · Reply
DragonAlgo
DragonAlgo Mar. 11 at 6:28 PM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-03-13 | Strike: $26.50 | Type: CALL Option Plan (premium): Entry: $0.75 Stop: $0.54 TP1: $0.98 TP2: $1.27 TP3: $1.80 Rules-based execution profile. 🔗 https://dragonalgo.com
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Mar. 11 at 6:05 PM
$PFE Whats better than going green five times in one day?
3 · Reply
dewmoore
dewmoore Mar. 11 at 5:36 PM
$SLS Great find @isthisonebetter -- folks keep dismissing the $PFE subdomain but I won't and THIS showcases Pfizer will be the aggressive buyout partner - just watch --- oh to the people --- here is what that role does - This role is essentially a "Hunter/Scout" for Big Pharma. Instead of developing drugs from scratch inside Pfizer's own labs, this person looks at small biotech companies to find the next big breakthrough. Find early-stage clinical assets (Phase 1 or Phase 2) that Pfizer can buy or partner with. Bridge to Business Development: They work with the finance/legal teams to structure buyouts or licensing deals. AI Integration: The post explicitly mentions using AI to accelerate development,....LOL folks just a matter of time! GLTA -- i think I will take ANOTHER 2k shares tomorrow or contracts hmmm don't know yet
0 · Reply
isthisonebetter
isthisonebetter Mar. 11 at 5:18 PM
$SLS 🤔 $PFE
1 · Reply
doubleuptwice
doubleuptwice Mar. 11 at 4:43 PM
$PFE bottom to top of range 4 times today. So basically repeating all of last week but doing it in a day. We should have a big spike coming soon here. Maybe tomorrow morning gap up on some news 🤫
0 · Reply
67X_ROI_Q1_2026
67X_ROI_Q1_2026 Mar. 11 at 4:34 PM
$SLS $PFE $ABBV $BMY Big Pharma’s know. +/- 60 Events right now, Just from the Control Arm while we await 80. --- Let it Sink in... I keep asking all the Paid Short Lowlife Working here to find 1 Trial for AML Cr2 Patients, not getting transplant with Any meaningful Survival Past 12 months, or any Patients on BAT Remaining alive at ALL past 24 months --- CRICKETS.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Mar. 11 at 4:09 PM
$PFE Weeeeeeeeee!!!!!!!!
1 · Reply
taxplanr
taxplanr Mar. 11 at 3:46 PM
$BNTX $MRNA $PFE Do you remember when ... https://www.instagram.com/reel/DVjfEuxj2Uy/?igsh=a3F5anphaTMxYm41
0 · Reply
taxplanr
taxplanr Mar. 11 at 2:03 PM
8 million person study shows massive increase in multiple cancers from $BNTX $MRNA $PFE bioweapons https://x.com/NicHulscher/status/2025972722480676869?s=20
0 · Reply
HeyHeyBooBoo
HeyHeyBooBoo Mar. 11 at 2:02 PM
$PFE 27.09 ish looks like a good entry point.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Mar. 11 at 2:01 PM
$PFE Should you buy? Should you sell? The market is very clear, you should do both!
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 11 at 1:58 PM
$PFE - Don't pforget our Meeting of Sufferers. April 23rd, 10:00 AM EST. Thursday.
0 · Reply
doubleuptwice
doubleuptwice Mar. 11 at 1:44 PM
$PFE buy signals all over the chart
1 · Reply
pineconecameo
pineconecameo Mar. 11 at 12:08 PM
$PFE $28 by eow!
0 · Reply